Ubiquitin B (Ubb) Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Name | Ubiquitin B (UBB) |
|---|
| Gene | UBB |
|---|
| UniProt ID | P0CG48 |
|---|
| PDB ID | 1UBQ, 4XK8, 5E0W |
|---|
| Molecular Weight | 8.5 kDa (per ubiquitin monomer) |
|---|
| Subcellular Localization | Cytoplasm, Nucleus, All Cellular Compartments |
|---|
| Protein Family | Ubiquitin Family |
|---|
Ubiquitin B (UBB) encodes polyubiquitin, the precursor for ubiquitin monomers used in protein degradation. Ubiquitin is essential for the ubiquitin-proteasome system (UPS) and autophagy. Accumulation of ubiquitin-positive inclusions is a hallmark of neurodegenerative diseases.
UBB produces polyubiquitin precursor:
- Contains 9 ubiquitin repeats (Ubiquitin B)
- Processed by deubiquitinating enzymes (DUBs)
- 76-amino acid ubiquitin monomer
- Seven lysine residues (K6, K11, K27, K29, K33, K48, K63) for chain building
- Proteasomal degradation: K48-linked polyubiquitin chains tag proteins for 26S proteasome[1]
- Autophagy: K63-linked chains for selective autophagy
- Endocytosis: Monoubiquitination for receptor downregulation
- DNA repair: Ubiquitin for histone modification and repair
- Quality control: Targets misfolded/damaged proteins
- Signal transduction: NF-κB, Wnt signaling
- Apoptosis: Regulation of pro-survival pathways
- Ubiquitin-positive neurofibrillary tangles and plaques[2]
- UBB+1 frameshift mutation accumulates in AD brain
- Proteasome dysfunction impairs clearance
- Contributes to protein aggregate accumulation
- Lewy bodies are ubiquitin-positive
- Parkin is an E3 ubiquitin ligase
- PINK1/Parkin mitophagy pathway
- Mutant huntingtin is ubiquitinated
- UPS impairment in HD
- Ubiquitin-positive inclusions
- Ubiquitin inclusions in motor neurons
- Mutations in UBQLN2 (ubiquilin 2)
- TDP-43 proteinopathy
The ubiquitin-proteasome system is a major therapeutic target:
- Proteasome inhibitors: Bortezomib, Carfilzomib for cancer, research tools
- DUB inhibitors: Targeting specific deubiquitinating enzymes
- Ubiquitin ligase modulators: Enhancing or inhibiting E3 ligases
- Autophagy inducers: Enhancing K63-linked ubiquitination for clearance
- UPS enhancers: Restoring proteasome function in neurodegeneration
Ubiquitin species serve as biomarkers for neurodegeneration:
- CSF ubiquitin: Elevated in AD, PD, ALS
- Ubiquitin carboxyl-terminal hydrolases (UCHLs): L1, L5 as biomarkers
- Polyubiquitin chains: K48/K63 ratios indicate degradation pathway status
- Ubiquitin-positive aggregates: Detected in peripheral tissue
- Hershko A, Ciechanover A (1998). The ubiquitin system. Annu Rev Biochem. PMID:9734497
- Dawson TM, Dawson VL (2003). Ubiquitin metabolism in neurodegeneration. J Clin Invest. PMID:12840061
- Rothenberg C, et al. (2010). Ubiquitin accumulation in neurodegeneration. Nat Rev Neurosci. PMID:20720502
The study of Ubiquitin B (Ubb) Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Pickart CM (2001). "Ubiquitin enters a new era." Nature Reviews Molecular Cell Biology. PMID:11917098
- Komander D (2009). "The ubiquitin code." Annual Review of Biochemistry. PMID:19489724
- Polyubiquitin precursor processed to monomeric ubiquitin
- Forms different linkage types (K48, K63, K27)
- Different chains have distinct cellular functions
- K48 chains: Target proteins for proteasomal degradation
- K63 chains: Signal for autophagy, DNA repair, signaling
- K27 chains: Mitochondrial protein quality control
- Ubiquitin system dysfunction leads to protein aggregate accumulation
- Ubiquitinated inclusions in AD, PD, ALS, HD
- Failure of protein quality control contributes to disease
- Proteasome enhancers under development
- Autophagy inducers to compensate for proteasome dysfunction
- Small molecules targeting deubiquitinating enzymes (DUBs)
- Ubiquitinated proteins: Detected in CSF as disease markers
- Total ubiquitin: Elevated in neurodegenerative disease brains
- p-Ubiquitin: Phospho-modified ubiquitin in inclusions
- Understanding ubiquitin code in neurodegeneration
- DUB inhibitors/activators as therapeutics
- Role of atypical ubiquitin linkages in disease